NCT00232440View on ClinicalTrials.gov

Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Hodgkin's DiseaseLymphoma, Non-Hodgkin
Interventions
DEVICE

BodyFIX

Trial Locations (1)

M5G 2M9

University Health Network, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT00232440 - Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma | Biotech Hunter | Biotech Hunter